Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 243

1.

Simultaneous Transdermal Delivery of Buprenorphine Hydrochloride and Naltrexone Hydrochloride by Iontophoresis.

Cordery SF, Husbands SM, Bailey CP, Guy RH, Delgado-Charro MB.

Mol Pharm. 2019 Jun 3;16(6):2808-2816. doi: 10.1021/acs.molpharmaceut.9b00337. Epub 2019 May 22.

PMID:
31070927
2.

Structuring and Supporting Excellence in Undergraduate Biochemistry and Molecular Biology Education: The ASBMB Degree Accreditation Program.

Del Gaizo Moore V, Loertscher J, Dean DM, Bailey CP, Kennelly PJ, Wolfson AJ.

CBE Life Sci Educ. 2018 Dec;17(4):le2. doi: 10.1187/cbe.18-09-0189. No abstract available.

3.

Cutting Edge Therapeutic Insights Derived from Molecular Biology of Pediatric High-Grade Glioma and Diffuse Intrinsic Pontine Glioma (DIPG).

Bailey CP, Figueroa M, Mohiuddin S, Zaky W, Chandra J.

Bioengineering (Basel). 2018 Oct 18;5(4). pii: E88. doi: 10.3390/bioengineering5040088. Review.

4.

Emerging areas of opioid pharmacology.

Kelly E, Henderson G, Bailey CP.

Br J Pharmacol. 2018 Jul;175(14):2715-2716. doi: 10.1111/bph.14343.

5.

Inhibition of alpha7 nicotinic receptors in the ventral hippocampus selectively attenuates reinstatement of morphine-conditioned place preference and associated changes in AMPA receptor binding.

Wright VL, Georgiou P, Bailey A, Heal DJ, Bailey CP, Wonnacott S.

Addict Biol. 2019 Jul;24(4):590-603. doi: 10.1111/adb.12624. Epub 2018 Apr 17.

6.

Antidepressant-like effects of BU10119, a novel buprenorphine analogue with mixed κ/μ receptor antagonist properties, in mice.

Almatroudi A, Ostovar M, Bailey CP, Husbands SM, Bailey SJ.

Br J Pharmacol. 2018 Jul;175(14):2869-2880. doi: 10.1111/bph.14060. Epub 2017 Nov 6.

7.

New interleukin-15 superagonist (IL-15SA) significantly enhances graft-versus-tumor activity.

Bailey CP, Budak-Alpdogan T, Sauter CT, Panis MM, Buyukgoz C, Jeng EK, Wong HC, Flomenberg N, Alpdogan O.

Oncotarget. 2017 Jul 4;8(27):44366-44378. doi: 10.18632/oncotarget.17875.

8.

Integration of inhibitory and excitatory effects of α7 nicotinic acetylcholine receptor activation in the prelimbic cortex regulates network activity and plasticity.

Udakis M, Wright VL, Wonnacott S, Bailey CP.

Neuropharmacology. 2016 Jun;105:618-629. doi: 10.1016/j.neuropharm.2016.02.028. Epub 2016 Feb 24.

9.

Induction of cell death by the novel proteasome inhibitor marizomib in glioblastoma in vitro and in vivo.

Manton CA, Johnson B, Singh M, Bailey CP, Bouchier-Hayes L, Chandra J.

Sci Rep. 2016 Jan 25;6:18953. doi: 10.1038/srep18953.

10.

Combined administration of buprenorphine and naltrexone produces antidepressant-like effects in mice.

Almatroudi A, Husbands SM, Bailey CP, Bailey SJ.

J Psychopharmacol. 2015 Jul;29(7):812-21. doi: 10.1177/0269881115586937. Epub 2015 Jun 4.

11.

Role of G Protein-Coupled Receptor Kinases 2 and 3 in μ-Opioid Receptor Desensitization and Internalization.

Lowe JD, Sanderson HS, Cooke AE, Ostovar M, Tsisanova E, Withey SL, Chavkin C, Husbands SM, Kelly E, Henderson G, Bailey CP.

Mol Pharmacol. 2015 Aug;88(2):347-56. doi: 10.1124/mol.115.098293. Epub 2015 May 26.

12.

Novel approaches for the treatment of psychostimulant and opioid abuse - focus on opioid receptor-based therapies.

Bailey CP, Husbands SM.

Expert Opin Drug Discov. 2014 Nov;9(11):1333-44. doi: 10.1517/17460441.2014.964203. Epub 2014 Sep 25. Review.

13.

A broadly implementable research course in phage discovery and genomics for first-year undergraduate students.

Jordan TC, Burnett SH, Carson S, Caruso SM, Clase K, DeJong RJ, Dennehy JJ, Denver DR, Dunbar D, Elgin SC, Findley AM, Gissendanner CR, Golebiewska UP, Guild N, Hartzog GA, Grillo WH, Hollowell GP, Hughes LE, Johnson A, King RA, Lewis LO, Li W, Rosenzweig F, Rubin MR, Saha MS, Sandoz J, Shaffer CD, Taylor B, Temple L, Vazquez E, Ware VC, Barker LP, Bradley KW, Jacobs-Sera D, Pope WH, Russell DA, Cresawn SG, Lopatto D, Bailey CP, Hatfull GF.

mBio. 2014 Feb 4;5(1):e01051-13. doi: 10.1128/mBio.01051-13.

14.

Functional selectivity and time-dependence of μ-opioid receptor desensitization at nerve terminals in the mouse ventral tegmental area.

Lowe JD, Bailey CP.

Br J Pharmacol. 2015 Jan;172(2):469-81. doi: 10.1111/bph.12605. Epub 2014 Jul 1.

15.

Ethanol reversal of cellular tolerance to morphine in rat locus coeruleus neurons.

Llorente J, Withey S, Rivero G, Cunningham M, Cooke A, Saxena K, McPherson J, Oldfield S, Dewey WL, Bailey CP, Kelly E, Henderson G.

Mol Pharmacol. 2013 Aug;84(2):252-60. doi: 10.1124/mol.113.085936. Epub 2013 May 28.

16.

Interleukin-15 administration increases graft-versus-tumor activity in recipients of haploidentical hematopoietic SCT.

Sauter CT, Bailey CP, Panis MM, Biswas CS, Budak-Alpdogan T, Durham A, Flomenberg N, Alpdogan O.

Bone Marrow Transplant. 2013 Sep;48(9):1237-42. doi: 10.1038/bmt.2013.47. Epub 2013 Apr 29.

PMID:
23624821
17.

Reversal of morphine analgesic tolerance by ethanol in the mouse.

Hull LC, Gabra BH, Bailey CP, Henderson G, Dewey WL.

J Pharmacol Exp Ther. 2013 Jun;345(3):512-9. doi: 10.1124/jpet.112.202184. Epub 2013 Mar 25.

18.

Haploidentical hematopoietic SCT increases graft-versus-tumor effect against renal cell carcinoma.

Budak-Alpdogan T, Sauter CT, Bailey CP, Biswas CS, Panis MM, Civriz S, Flomenberg N, Alpdogan O.

Bone Marrow Transplant. 2013 Aug;48(8):1084-90. doi: 10.1038/bmt.2013.9. Epub 2013 Feb 25.

PMID:
23435516
19.

A non-rewarding, non-aversive buprenorphine/naltrexone combination attenuates drug-primed reinstatement to cocaine and morphine in rats in a conditioned place preference paradigm.

Cordery SF, Taverner A, Ridzwan IE, Guy RH, Delgado-Charro MB, Husbands SM, Bailey CP.

Addict Biol. 2014 Jul;19(4):575-86. doi: 10.1111/adb.12020. Epub 2012 Dec 14.

PMID:
23240906
20.

Double haploidentical hematopoietic stem cell transplantation results in successful engraftment of bone marrow from both donors without graft-versus-host or graft-versus-graft effects.

Biswas CS, Sauter CT, Bailey CP, Rittenberg D, Luo X, Panis MM, Budak-Alpdogan T, Grosso D, Flomenberg N, Alpdogan O.

Biol Blood Marrow Transplant. 2012 Dec;18(12):1808-18. doi: 10.1016/j.bbmt.2012.09.012. Epub 2012 Oct 16.

21.

μ-Opioid receptor desensitization: homologous or heterologous?

Llorente J, Lowe JD, Sanderson HS, Tsisanova E, Kelly E, Henderson G, Bailey CP.

Eur J Neurosci. 2012 Dec;36(12):3636-42. doi: 10.1111/ejn.12003. Epub 2012 Sep 24.

22.

Endomorphin-2: a biased agonist at the μ-opioid receptor.

Rivero G, Llorente J, McPherson J, Cooke A, Mundell SJ, McArdle CA, Rosethorne EM, Charlton SJ, Krasel C, Bailey CP, Henderson G, Kelly E.

Mol Pharmacol. 2012 Aug;82(2):178-88. doi: 10.1124/mol.112.078659. Epub 2012 May 2.

23.

Development and analysis of an instrument to assess student understanding of foundational concepts before biochemistry coursework.

Villafañe SM, Bailey CP, Loertscher J, Minderhout V, Lewis JE.

Biochem Mol Biol Educ. 2011 Mar-Apr;39(2):102-9. doi: 10.1002/bmb.20464.

24.

Probabilistic peak calling and controlling false discovery rate estimations in transcription factor binding site mapping from ChIP-seq.

Jiao S, Bailey CP, Zhang S, Ladunga I.

Methods Mol Biol. 2010;674:161-77. doi: 10.1007/978-1-60761-854-6_10.

PMID:
20827591
25.

μ-opioid receptors: correlation of agonist efficacy for signalling with ability to activate internalization.

McPherson J, Rivero G, Baptist M, Llorente J, Al-Sabah S, Krasel C, Dewey WL, Bailey CP, Rosethorne EM, Charlton SJ, Henderson G, Kelly E.

Mol Pharmacol. 2010 Oct;78(4):756-66. doi: 10.1124/mol.110.066613. Epub 2010 Jul 20.

26.

Involvement of PKC alpha and G-protein-coupled receptor kinase 2 in agonist-selective desensitization of mu-opioid receptors in mature brain neurons.

Bailey CP, Oldfield S, Llorente J, Caunt CJ, Teschemacher AG, Roberts L, McArdle CA, Smith FL, Dewey WL, Kelly E, Henderson G.

Br J Pharmacol. 2009 Sep;158(1):157-64. doi: 10.1111/j.1476-5381.2009.00140.x. Epub 2009 Mar 20.

27.

Glutamate-induced post-activation inhibition of locus coeruleus neurons is mediated by AMPA/kainate receptors and sodium-dependent potassium currents.

Zamalloa T, Bailey CP, Pineda J.

Br J Pharmacol. 2009 Feb;156(4):649-61. doi: 10.1111/j.1476-5381.2008.00004.x.

28.

Role of protein kinase C and mu-opioid receptor (MOPr) desensitization in tolerance to morphine in rat locus coeruleus neurons.

Bailey CP, Llorente J, Gabra BH, Smith FL, Dewey WL, Kelly E, Henderson G.

Eur J Neurosci. 2009 Jan;29(2):307-18. doi: 10.1111/j.1460-9568.2008.06573.x.

30.

Pre-treatment with a PKC or PKA inhibitor prevents the development of morphine tolerance but not physical dependence in mice.

Gabra BH, Bailey CP, Kelly E, Smith FL, Henderson G, Dewey WL.

Brain Res. 2008 Jun 27;1217:70-7. doi: 10.1016/j.brainres.2008.04.036. Epub 2008 Apr 24.

31.

The small ubiquitin-like modifier (SUMO) and SUMO-conjugating system of Chlamydomonas reinhardtii.

Wang Y, Ladunga I, Miller AR, Horken KM, Plucinak T, Weeks DP, Bailey CP.

Genetics. 2008 May;179(1):177-92. doi: 10.1534/genetics.108.089128.

32.

Galpha(i2) inhibition of adenylate cyclase regulates presynaptic activity and unmasks cGMP-dependent long-term depression at Schaffer collateral-CA1 hippocampal synapses.

Bailey CP, Nicholls RE, Zhang XL, Zhou ZY, Müller W, Kandel ER, Stanton PK.

Learn Mem. 2008 Apr 7;15(4):261-70. doi: 10.1101/lm.810208. Print 2008 Apr.

33.

Methadone: does it really have low efficacy at micro-opioid receptors?

Rodriguez-Martin I, Braksator E, Bailey CP, Goodchild S, Marrion NV, Kelly E, Henderson G.

Neuroreport. 2008 Mar 26;19(5):589-93. doi: 10.1097/WNR.0b013e3282f97b64.

PMID:
18388744
34.

Use of a laboratory exercise on molar absorptivity to help students understand the authority of the primary literature.

Soundararajan M, Bailey CP, Markwell J.

Biochem Mol Biol Educ. 2008 Jan;36(1):61-4. doi: 10.1002/bmb.20144.

35.

Agonist-selective mechanisms of GPCR desensitization.

Kelly E, Bailey CP, Henderson G.

Br J Pharmacol. 2008 Mar;153 Suppl 1:S379-88. Epub 2007 Dec 3. Review.

36.

C-terminal splice variants of the mu-opioid receptor: existence, distribution and functional characteristics.

Oldfield S, Braksator E, Rodriguez-Martin I, Bailey CP, Donaldson LF, Henderson G, Kelly E.

J Neurochem. 2008 Feb;104(4):937-45. Epub 2007 Nov 14.

37.

Evidence for an important role of protein phosphatases in the mechanism of morphine tolerance.

Gabra BH, Bailey CP, Kelly E, Sanders AV, Henderson G, Smith FL, Dewey WL.

Brain Res. 2007 Jul 23;1159:86-93. Epub 2007 May 21.

38.

How important is protein kinase C in mu-opioid receptor desensitization and morphine tolerance?

Bailey CP, Smith FL, Kelly E, Dewey WL, Henderson G.

Trends Pharmacol Sci. 2006 Nov;27(11):558-65. Epub 2006 Sep 25.

PMID:
17000011
39.

Agonist-selective mechanisms of mu-opioid receptor desensitization in human embryonic kidney 293 cells.

Johnson EA, Oldfield S, Braksator E, Gonzalez-Cuello A, Couch D, Hall KJ, Mundell SJ, Bailey CP, Kelly E, Henderson G.

Mol Pharmacol. 2006 Aug;70(2):676-85. Epub 2006 May 8.

PMID:
16682505
40.

mGluR2 acts through inhibitory Galpha subunits to regulate transmission and long-term plasticity at hippocampal mossy fiber-CA3 synapses.

Nicholls RE, Zhang XL, Bailey CP, Conklin BR, Kandel ER, Stanton PK.

Proc Natl Acad Sci U S A. 2006 Apr 18;103(16):6380-5. Epub 2006 Apr 10.

41.

Opioids: cellular mechanisms of tolerance and physical dependence.

Bailey CP, Connor M.

Curr Opin Pharmacol. 2005 Feb;5(1):60-8. Review.

PMID:
15661627
42.

Protein kinase C activation enhances morphine-induced rapid desensitization of mu-opioid receptors in mature rat locus ceruleus neurons.

Bailey CP, Kelly E, Henderson G.

Mol Pharmacol. 2004 Dec;66(6):1592-8. Epub 2004 Sep 10.

PMID:
15361548
43.
44.

Mu-opioid receptor desensitization in mature rat neurons: lack of interaction between DAMGO and morphine.

Bailey CP, Couch D, Johnson E, Griffiths K, Kelly E, Henderson G.

J Neurosci. 2003 Nov 19;23(33):10515-20.

45.

Long-term depression of presynaptic release from the readily releasable vesicle pool induced by NMDA receptor-dependent retrograde nitric oxide.

Stanton PK, Winterer J, Bailey CP, Kyrozis A, Raginov I, Laube G, Veh RW, Nguyen CQ, Müller W.

J Neurosci. 2003 Jul 2;23(13):5936-44.

46.
47.

Alterations in mesolimbic dopamine function during the abstinence period following chronic ethanol consumption.

Bailey CP, O'Callaghan MJ, Croft AP, Manley SJ, Little HJ.

Neuropharmacology. 2001 Dec;41(8):989-99.

PMID:
11747903
48.

Prolonged changes in neurochemistry of dopamine neurones after chronic ethanol consumption.

Bailey CP, Andrews N, McKnight AT, Hughes J, Little HJ.

Pharmacol Biochem Behav. 2000 May;66(1):153-61.

PMID:
10837855
49.

Cationic oligonucleotides can mediate specific inhibition of gene expression in Xenopus oocytes.

Bailey CP, Dagle JM, Weeks DL.

Nucleic Acids Res. 1998 Nov 1;26(21):4860-7.

50.

Chronic ethanol administration alters activity in ventral tegmental area neurons after cessation of withdrawal hyperexcitability.

Bailey CP, Manley SJ, Watson WP, Wonnacott S, Molleman A, Little HJ.

Brain Res. 1998 Aug 24;803(1-2):144-52.

PMID:
9729345

Supplemental Content

Loading ...
Support Center